Key takeaways
- The 2020 U.S. allergy guideline cites estimates that 17% to 52% of adults have chronic non-allergic rhinitis, and says up to 34% of U.S. rhinitis patients may have both kinds1.
- Skin prick or blood IgE tests, chosen to fit your history, can confirm an allergy; the allergy academy says IgG testing is not a test for allergic conditions14.
- In April 2026, Britain’s drug regulator cut its limit for decongestant nose sprays from seven days to five because of rebound congestion; a U.S. drug guide says no more than three days in a row without checking with your care team56.
- Allergy shots take about 4 to 6 months to build up, then 3 to 5 years of maintenance doses, and lasting relief is most likely after at least three years7.
- In a five-year trial of 812 children, a grass allergy tablet cut hay fever symptoms 22% to 30% a year but didn’t delay the start of asthma1112.
On April 30, 2026, Britain’s medicines regulator changed its advice for decongestant nose sprays containing oxymetazoline or xylometazoline. The maximum stretch of use dropped from seven days to five5.
The reason wasn’t a rare side effect. It was a familiar one. With overuse, the stuffiness comes back harder as each dose fades, and it’s easy to blame the cold or allergy you started with5. Left unchecked for long enough, the overuse can permanently alter the inside of the nose5.
That’s one way a stuffy nose can fool you. Here’s another. Some people who assume they have allergies don’t, or don’t only have allergies. The 2020 allergy guideline cites estimates that 17% to 52% of adults have chronic non-allergic rhinitis1.
Getting the type right matters, because treatments differ. And for true allergy, there’s one kind of treatment that does more than ease symptoms. Allergy shots and tablets use the allergen itself to build tolerance over years79.
This guide covers how to tell the types apart, which tests are worth doing, how to avoid the decongestant trap and what immunotherapy can and can’t do. Our companion article on seasonal allergies covers pollen timing, drugstore basics and natural remedies.
Allergic, non-allergic or both
Rhinitis just means an inflamed nose: congestion, a runny nose, sneezing or postnasal drip.
In allergic rhinitis, the immune system treats something harmless, such as pollen or dust mites, as a threat. Classic hay fever brings sneezing, stuffiness, a runny nose and itching in the nose, roof of the mouth, throat, eyes or ears10.
Non-allergic rhinitis looks similar but has no allergic trigger. A 2012 review in the Cleveland Clinic Journal of Medicine laid out the usual clues2:
- It tends to start later in life.
- Congestion and clear drip dominate, with less sneezing and itching.
- Smoke, fumes, strong scents, a meal or a swing in the weather can set it off. Animals don’t.
- Antihistamine pills often don’t help, and there’s usually no personal or family history of allergy.
Some types have specific triggers. Gustatory rhinitis brings a runny nose with eating or drinking alcohol2. Some medicines can cause stuffiness, including certain blood pressure drugs, erectile dysfunction drugs and birth control pills2. If you suspect a medicine, talk with the prescriber rather than stopping it yourself.
The categories also overlap. Up to 34% of U.S. rhinitis patients may have both allergic and non-allergic rhinitis, which doctors call mixed rhinitis1.
A newer idea, local allergic rhinitis, describes allergy-like reactions confined to the nose. Some studies have found it in up to 26% of people with rhinitis, the 2020 guideline notes1. That’s one reason a negative test doesn’t always end the story.
Is it allergy? The rhinitis sorter
This table is a starting point for a conversation with a clinician, not a diagnosis. Patterns overlap, and many people fit more than one row.
| If your pattern is… | It may be… | Test or treatment to ask about |
|---|---|---|
| Sneezing and itchy nose, eyes or palate that flare in the same season each year | Seasonal allergic rhinitis | Steroid nose spray first; skin prick or blood IgE test if treatment fails or the cause is unclear1310 |
| The same itch and sneezing all year, or worse around pets or dust | Year-round (perennial) allergic rhinitis | Targeted skin or blood IgE tests, matched to your history134 |
| Congestion and clear drip that began in adulthood, set off by smoke, perfume, fumes or weather; little itching | Non-allergic (vasomotor) rhinitis | Tests mainly to rule out allergy; steroid or antihistamine nose sprays12 |
| Runny nose when you eat or drink alcohol | Gustatory rhinitis | An ipratropium nose spray, which targets drip12 |
| Stuffiness that returns hours after each decongestant spray, after days of use | Rebound congestion (rhinitis medicamentosa) | A plan with your clinician to break the cycle25 |
| Stuffiness that began after starting a new medicine | Drug-induced rhinitis | Ask the prescriber; don’t stop a medicine on your own2 |
| Allergy-like symptoms but negative standard tests | Local allergic rhinitis, or non-allergic rhinitis | Ask an allergist about further evaluation1 |
| Discolored drainage and blockage lasting more than 12 weeks | Chronic rhinosinusitis | Referral to an ear, nose and throat doctor or allergist if first treatment fails2 |
Allergy tests that answer a real question
A good allergy test confirms something your history already suggests. It isn’t a fishing trip.
The 2015 ear, nose and throat guideline says clinicians should test for specific IgE, the allergy antibody, when treatment hasn’t worked, the diagnosis is uncertain, or the exact allergen needs to be known3. The 2020 allergy guideline agrees that skin prick or blood IgE testing should confirm allergic rhinitis in people whose history fits1.
Skin prick test. A tiny amount of a suspected allergen is pricked into the skin to see whether a raised, itchy bump appears.
Blood test. A lab measures IgE antibodies aimed at specific allergens. Either kind of result means most when it lines up with your symptoms4.
Bigger isn’t better. In its 2012 Choosing Wisely list, the American Academy of Allergy, Asthma & Immunology (AAAAI) warned against ordering large batches of IgE tests without a specific reason4. Food tests in particular often come back positive in people who have no food allergy, and inhalant tests do so less often4. Without a history pointing to an allergen, a positive can suggest an allergy you don’t have4.
The 2020 guideline adds that food allergy testing isn’t recommended as a routine part of checking out a stuffy nose1.
IgG tests are a different matter. The AAAAI states plainly that “specific IgG testing is not a test for an allergic condition”4. Our article on IgG food tests explains what those panels measure instead.
Scans aren’t routine either. The 2015 guideline recommends against sinus imaging for symptoms that fit allergic rhinitis3.
The spray that causes the stuffiness it treats
Decongestant nose sprays such as oxymetazoline and xylometazoline are meant for short-term relief of a blocked nose5. The quick relief is what makes them easy to overuse.
Britain’s 2026 review named three linked problems5:
- Rebound congestion. Each time a dose fades, the nose gets more blocked than before.
- Tachyphylaxis. The spray loses punch, so people use it more often to get the same relief.
- Rhinitis medicamentosa. Months of overuse bring constant, heavy congestion and changes a doctor can see inside the nose. At its worst, untreated, the damage may be lasting and need surgery to fix.
Labels differ by country. Britain now says no more than five days in a row for adults and children 12 and older5. In the U.S., the Cleveland Clinic’s guide to oxymetazoline says not to go past three days in a row without talking to your care team6. The U.S. allergy guideline also calls for short-term use, allowing longer courses alongside a steroid spray only in limited cases1.
There’s good news, too. The British regulator says that when the problem is spotted and treated early, people typically recover fully within three months5. Quitting can be hard, and it may take more than one try2. Talk with a clinician if you’re having trouble stopping, or if congestion persists or worsens5.
Immunotherapy retrains the allergy, slowly
Sprays and pills ease symptoms. Allergen immunotherapy targets the immune cause of the allergy, as the researchers behind a major children’s trial put it11. It gives gradually rising doses of the allergen you react to, so your immune system can build tolerance7.
That idea fits many natural-health values: working with the body, using the trigger itself and aiming for lasting change. But it’s still a medical treatment with real risks, given under an allergist’s supervision.
Allergy shots. Children can start at age 5, once an allergist has confirmed that something in the environment, such as grass pollen or dust mites, is behind the symptoms7. First comes a build-up stretch: one or two shots a week, with the dose rising, for roughly four to six months. Then maintenance: a shot every two to four weeks, kept up for three to five years7.
Sticking with it pays off. The AAAAI says benefits are most likely to last when people complete three or more years, and they may continue after the shots end7. Someone who sees no change a year into maintenance should talk with the allergist about other paths7.
A red, swollen spot on the arm is the usual side effect. A severe whole-body allergic reaction, called anaphylaxis, is uncommon, and deaths are extremely rare7. Because most serious reactions begin within half an hour, patients stay in the office for 30 minutes after every shot8. Shots belong in a health care setting, not at home7.
Under-the-tongue tablets. Four tablets appear in the AAAAI’s 2026 drug guide, each listed for ages 5 to 659:
- Grastek, for timothy and related grasses
- Oralair, a mix of five grasses
- Ragwitek, for short ragweed
- Odactra, for house dust mite, taken daily all year
Each carries an FDA boxed warning for serious safety risks, and the first dose is taken in a doctor’s office9. Odactra’s FDA label, revised in June 2026, confirms the 5-to-65 age range and calls for watching patients for at least 30 minutes after that first dose14. Timing matters, too. Grastek and Ragwitek start 12 weeks before the pollen season, and Oralair at least four months before9.
Tell your allergist about every medicine you take8. Shots aren’t started during pregnancy, though they can continue if pregnancy begins during treatment8.
Can treating allergies early prevent asthma?
Allergies and asthma often travel together. Both major guidelines tell clinicians to look for asthma in people with allergic rhinitis13.
The AAAAI says allergy shots may lower children’s risk of developing asthma7. The strongest test of that idea for tablets came from the GAP trial, which researchers described as the first double-blind, placebo-controlled trial of immunotherapy to prevent asthma13.
Researchers enrolled 812 children aged 5 to 12 with grass pollen allergy and no asthma, at 101 centers in 11 European countries1112. About half took a grass tablet called Grazax and the rest took a placebo for three years. Then everyone was followed for two more1113.
The main result was a miss. Asthma began in 34 of 398 children on the tablet and 38 of 414 on placebo, a difference that wasn’t statistically significant12. By our math, that’s about 8.5% versus 9.2%, or roughly 6 fewer cases per 1,000 children, a gap that could be chance.
Other results looked better. Children on the tablet had about one-third lower odds of asthma symptoms or asthma medicine use (an odds ratio of 0.66). Their hay fever symptoms ran 22% to 30% lower than placebo in each of the five years11.
None of the trial records we could open named a funder, so we can’t say whether the tablet’s maker paid for the study. That’s worth knowing, because the product is sold commercially.
Our article on asthma covers that condition’s treatment.
How strong is the evidence?
| Approach | Evidence rating | What it rests on |
|---|---|---|
| Skin prick or blood IgE tests, guided by history | Recommended by both U.S. guidelines134 | |
| IgG tests for allergy | Not a test for allergic conditions4 | |
| Large IgE panels with no matching history | False positives can suggest allergies you don’t have4 | |
| Allergy shots for allergic rhinitis | Guideline recommendation when medicines fall short37 | |
| Grass allergy tablet for hay fever | Symptoms 22% to 30% lower each year in a five-year trial; guideline backing311 | |
| Immunotherapy to prevent asthma in children | Fewer asthma symptoms, but no delay in asthma onset71112 | |
| Antihistamine nose sprays for non-allergic rhinitis | A strong first-line recommendation in the 2020 guideline, though another of its statements grades the evidence lower1 | |
| Steroid nose sprays for non-allergic rhinitis | Suggested first-line, but on low-certainty evidence1 | |
| Decongestant sprays beyond a few days | Rebound, loss of effect and lasting nasal damage5 |
When to see an allergist
Self-care handles a lot of nasal trouble, but some situations call for a specialist. Ask for a referral if:
- Treatment hasn’t helped, or the cause of your symptoms is unclear3.
- Your seasons are long or severe, medicines don’t control them, or you’d rather not take medicine for years. These are common reasons to consider allergy shots, the AAAAI says7.
- You can’t stop using a decongestant spray, or congestion persists or worsens5.
- You wheeze or have other signs of asthma along with nasal symptoms, since guidelines call for checking13.
- Blocked, discolored drainage lasts for weeks despite treatment2.
If you’re on allergy shots, stay the full 30 minutes after each one, since most serious reactions start in that window8.
Future articles in this series will cover how to recognize serious breathing symptoms and how to find qualified allergy care.
Questions readers ask
Will an IgG food sensitivity test explain my stuffy nose?
No. The AAAAI says specific IgG testing isn’t a test for allergic conditions, and the 2020 guideline doesn’t recommend routine food allergy testing for rhinitis14. Our article on IgG food tests covers why.
Do allergy shots cure allergies?
They can bring relief that lasts after treatment ends, most likely after at least three years of shots7. They don’t work for everyone, so the AAAAI says to revisit the plan if nothing has improved after a year of maintenance7.
Are tablets safer than shots because you take them at home?
Both carry real risks. Each tablet has an FDA boxed warning and starts with a first dose in a doctor’s office9. Shots are given only in a health care setting, with a 30-minute wait afterward78.
Can I get allergy shots while pregnant?
Allergists don’t start shots during pregnancy, but they can continue them if you become pregnant during treatment8.
The bottom line
A stuffy nose that won’t quit can be allergic, non-allergic, both, or a rebound from the spray meant to fix it. Sorting out which one you have is the step that makes every treatment work better.
Targeted skin or blood IgE tests can confirm an allergy, while IgG panels can’t. Decongestant sprays belong in short bursts. And for true allergy that medicines don’t control, shots and tablets offer something rare: a slow, supervised way to change the immune response itself.
Related reading
About this article
This article was researched using U.S. allergy and otolaryngology guidelines, allergy society patient resources, a British drug safety update, an FDA-approved drug label and peer-reviewed trials, all listed below. It was reviewed in October 2026. It is general education, not medical, legal or financial advice.
Sources
- Dykewicz MS, Wallace DV, Amrol DJ, et al. “Rhinitis 2020: A practice parameter update.” Journal of Allergy and Clinical Immunology, 2020;146(4):721-767. college.acaai.org
- Schroer B, Pien LC. “Nonallergic rhinitis: Common problem, chronic symptoms.” Cleveland Clinic Journal of Medicine, 2012;79(4):285-293. pubmed.ncbi.nlm.nih.gov
- American Academy of Otolaryngology–Head and Neck Surgery. “Clinical Practice Guideline: Allergic Rhinitis” (summary of Seidman MD, Gurgel RK, Lin SY, et al., Otolaryngology–Head and Neck Surgery, 2015). AAO-HNS Bulletin, February 6, 2015.
- American Academy of Allergy, Asthma & Immunology. “Five Things Physicians and Patients Should Question” (Choosing Wisely). AAAAI, April 4, 2012. aaaai.org
- Medicines and Healthcare products Regulatory Agency. “Nasal decongestant sprays and drops containing xylometazoline hydrochloride/oxymetazoline hydrochloride: increased risk of rebound congestion (rhinitis medicamentosa) and tachyphylaxis with overuse.” Drug Safety Update, April 30, 2026. gov.uk
- Cleveland Clinic. “Oxymetazoline Nasal Spray.” Cleveland Clinic Health Library, accessed October 2026. my.clevelandclinic.org
- American Academy of Allergy, Asthma & Immunology. “Allergy Shots (Immunotherapy).” AAAAI Conditions Library, page dated September 16, 2026.)
- American Academy of Allergy, Asthma & Immunology. “Allergy Shot Tips.” AAAAI Conditions Library, page dated June 18, 2026. aaaai.org
- American Academy of Allergy, Asthma & Immunology. “Sublingual Immunotherapy (SLIT) Allergy Tablets.” AAAAI Drug Guide, last updated March 2026. aaaai.org
- American Academy of Allergy, Asthma & Immunology. “Hay Fever and Pollen Counts.” AAAAI Conditions Library, page dated July 16, 2026. aaaai.org
- Valovirta E, Petersen TH, Piotrowska T, et al. “Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy.” Journal of Allergy and Clinical Immunology, 2018 (published online 2017). University of Turku repository record. pubmed.ncbi.nlm.nih.gov
- Heinzl S. “Gräserpollenallergie: Seltener Asthma nach sublingualer Immuntherapie.” Deutsches Ärzteblatt, November 2017. aerzteblatt.de
- Custovic A, Valovirta E, Berstad AKH, et al. “Design and Recruitment for the GAP Trial, Investigating the Preventive Effect on Asthma Development of an SQ-Standardized Grass Allergy Immunotherapy Tablet in Children with Grass Pollen-Induced Allergic Rhinoconjunctivitis.” Clinical Therapeutics, 2011;33(10):1537-1546. research.manchester.ac.uk
- U.S. Food and Drug Administration. “ODACTRA (House Dust Mite Allergen Extract) Tablet for Sublingual Use: Full Prescribing Information.” ALK-Abelló, revised June 2026. fda.gov